DarioHealth (DRIO) Receivables (2013 - 2026)

DarioHealth's Receivables history runs 14 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• Quarterly Receivables rose 42.48% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 42.48% YoY) and the FY2025 annual result came in at -$516000.0, down 116.52% from the prior year.
• Receivables was $2.3 million for Q1 2026 at DarioHealth, up from $1.9 million in the prior quarter.
• Across five years, Receivables topped out at $9.3 million in Q1 2024 and bottomed at -$822000.0 in Q1 2023.
• A 5-year average of $4.0 million and a median of $3.2 million in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2022 — Receivables soared 5125.33% — and 2023, when it sank 110.49%.
• DarioHealth's Receivables stood at $8.3 million in 2022, then sank by 78.62% to $1.8 million in 2023, then surged by 162.24% to $4.7 million in 2024, then plunged by 58.95% to $1.9 million in 2025, then grew by 19.92% to $2.3 million in 2026.
• Business Quant data shows DRIO's Receivables at $2.3 million in Q1 2026, $1.9 million in Q4 2025, and $2.2 million in Q3 2025.